Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet
Lycopene (LY) belongs to carotenoids and is abundant in red fruits and vegetables. Several previous studies suggested that LY is beneficial for ameliorating non-alcoholic fatty liver disease (NAFLD), while the potential mechanisms are unclear. The present study aimed to clarify the potential mechani...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2023.1120254/full |
_version_ | 1797862093729300480 |
---|---|
author | Xiang Gao Xiang Gao Xia Zhao Min Liu Huimin Zhao Yongye Sun |
author_facet | Xiang Gao Xiang Gao Xia Zhao Min Liu Huimin Zhao Yongye Sun |
author_sort | Xiang Gao |
collection | DOAJ |
description | Lycopene (LY) belongs to carotenoids and is abundant in red fruits and vegetables. Several previous studies suggested that LY is beneficial for ameliorating non-alcoholic fatty liver disease (NAFLD), while the potential mechanisms are unclear. The present study aimed to clarify the potential mechanisms of LY in preventing NAFLD via exploring the hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota composition in high-fat and high-fructose diet (HFFD)-fed mice. Fifty eight-week-old male C57BL/6J mice were randomly assigned into 5 groups: Normal control group (NC); HFFD group; HFFD with low dose of lycopene group (LLY, 20 mg/kg/d); HFFD with high dose of lycopene group (HLY, 60 mg/kg/d) and HFFD with resveratrol group (RSV, 50 mg/kg/d, positive control). After 8 weeks, feces were collected and the 12 h fasted mice were sacrificed to acquire tissues and blood for parameters measurement. The results showed that the mice in LLY, HLY and RSV groups had significantly lower body weight gain, weight of white adipose tissue, serum levels of high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), lipopolysaccharide (LPS), alanine aminotransferase (ALT), and hepatic concentrations of triglyceride (TG) and interleukin-6 (IL-6) than that in the HFFD group (p < 0.05). HLY and RSV groups also displayed lower serum levels of TG, total cholesterol (TC) and hepatic levels of tumor necrosis factor-α (TNF-α) than the HFFD group (p < 0.05). Liver protein expressions of NLRP3, Pro-Caspase-1, Caspase-1 and NF-κB were lower in the LLY, HLY and RSV groups than those in the HFFD group (p < 0.05). The feces of LY -treated mice had higher relative levels of SCFAs producing bacteria Allobaculum and lower destructive bacteria, including Firmicutes, Lachnospiraceae_NK4A136_group, Desulfovibrio, and Alistipes over the HFFD group (p < 0.05). RSV group also displayed lower fecal levels of Lachnospiraceae_NK4A136_group, Desulfovibrio, and Alistipes than the HFFD group (p < 0.05). In conclusion, LY might prevent NAFLD by suppressing hepatic NF-κB/NLRP3 inflammasome pathway and attenuating gut microbiota dysbiosis. |
first_indexed | 2024-04-09T22:13:44Z |
format | Article |
id | doaj.art-40edcdabf290473c81192f24241cdd4f |
institution | Directory Open Access Journal |
issn | 2296-861X |
language | English |
last_indexed | 2024-04-09T22:13:44Z |
publishDate | 2023-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Nutrition |
spelling | doaj.art-40edcdabf290473c81192f24241cdd4f2023-03-23T04:56:41ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2023-03-011010.3389/fnut.2023.11202541120254Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose dietXiang Gao0Xiang Gao1Xia Zhao2Min Liu3Huimin Zhao4Yongye Sun5Institute of Nutrition and Health, College of Public Health, Qingdao University, Qingdao, ChinaCollege of Life Sciences, Qingdao University, Qingdao, ChinaDepartment of Pediatric Dentistry, Qingdao Stomatological Hospital Affiliated to Qingdao University, Qingdao, ChinaDepartment of Diet and Nutrition, Shandong Provincial Chronic Disease Hospital, Qingdao, ChinaInstitute of Nutrition and Health, College of Public Health, Qingdao University, Qingdao, ChinaInstitute of Nutrition and Health, College of Public Health, Qingdao University, Qingdao, ChinaLycopene (LY) belongs to carotenoids and is abundant in red fruits and vegetables. Several previous studies suggested that LY is beneficial for ameliorating non-alcoholic fatty liver disease (NAFLD), while the potential mechanisms are unclear. The present study aimed to clarify the potential mechanisms of LY in preventing NAFLD via exploring the hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota composition in high-fat and high-fructose diet (HFFD)-fed mice. Fifty eight-week-old male C57BL/6J mice were randomly assigned into 5 groups: Normal control group (NC); HFFD group; HFFD with low dose of lycopene group (LLY, 20 mg/kg/d); HFFD with high dose of lycopene group (HLY, 60 mg/kg/d) and HFFD with resveratrol group (RSV, 50 mg/kg/d, positive control). After 8 weeks, feces were collected and the 12 h fasted mice were sacrificed to acquire tissues and blood for parameters measurement. The results showed that the mice in LLY, HLY and RSV groups had significantly lower body weight gain, weight of white adipose tissue, serum levels of high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), lipopolysaccharide (LPS), alanine aminotransferase (ALT), and hepatic concentrations of triglyceride (TG) and interleukin-6 (IL-6) than that in the HFFD group (p < 0.05). HLY and RSV groups also displayed lower serum levels of TG, total cholesterol (TC) and hepatic levels of tumor necrosis factor-α (TNF-α) than the HFFD group (p < 0.05). Liver protein expressions of NLRP3, Pro-Caspase-1, Caspase-1 and NF-κB were lower in the LLY, HLY and RSV groups than those in the HFFD group (p < 0.05). The feces of LY -treated mice had higher relative levels of SCFAs producing bacteria Allobaculum and lower destructive bacteria, including Firmicutes, Lachnospiraceae_NK4A136_group, Desulfovibrio, and Alistipes over the HFFD group (p < 0.05). RSV group also displayed lower fecal levels of Lachnospiraceae_NK4A136_group, Desulfovibrio, and Alistipes than the HFFD group (p < 0.05). In conclusion, LY might prevent NAFLD by suppressing hepatic NF-κB/NLRP3 inflammasome pathway and attenuating gut microbiota dysbiosis.https://www.frontiersin.org/articles/10.3389/fnut.2023.1120254/fulllycopeneNLRP3nonalcoholic fatty liver diseaseintestinal microbiotamice |
spellingShingle | Xiang Gao Xiang Gao Xia Zhao Min Liu Huimin Zhao Yongye Sun Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet Frontiers in Nutrition lycopene NLRP3 nonalcoholic fatty liver disease intestinal microbiota mice |
title | Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet |
title_full | Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet |
title_fullStr | Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet |
title_full_unstemmed | Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet |
title_short | Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet |
title_sort | lycopene prevents non alcoholic fatty liver disease through regulating hepatic nf κb nlrp3 inflammasome pathway and intestinal microbiota in mice fed with high fat and high fructose diet |
topic | lycopene NLRP3 nonalcoholic fatty liver disease intestinal microbiota mice |
url | https://www.frontiersin.org/articles/10.3389/fnut.2023.1120254/full |
work_keys_str_mv | AT xianggao lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet AT xianggao lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet AT xiazhao lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet AT minliu lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet AT huiminzhao lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet AT yongyesun lycopenepreventsnonalcoholicfattyliverdiseasethroughregulatinghepaticnfkbnlrp3inflammasomepathwayandintestinalmicrobiotainmicefedwithhighfatandhighfructosediet |